Test Updates

SARS-CoV-2 (COVID-19) Nasal Collections for Non-Exposure Patients

On August 3, 2020 Clinical Labs of Hawaii will begin offering nasal (anterior nares) collection of SARS-CoV-2 specimens at select locations.

SARS-CoV-2 (COVID-19) Testing - Patient Data Collection Requirement

On June 4, 2020, the U.S. Department of Health and Human Services (HHS) published new requirements for patient data collection and reporting for COVID-19 test results. Please review this bulletin for more details.

SARS-CoV-2 (COVID-19) Molecular Testing - Specimen Types

Please review the Clinical Labs of Hawaii frequently asked questions for answers regarding SARS-CoV-2 (COVID-19) molecular testing specimen types.

SARS-CoV-2 (COVID-19) Molecular Testing

On May 19, 2020, Clinical Laboratories of Hawaii (CLH) began testing for SARS-CoV-2, the virus that causes COVID-19, using a new high-throughput system, called the Aptima® SARS-CoV-2 Assay conducted on the Hologic Panther instrument.

COVID-19 Uninsured Program

Please review guidelines from the federal government’s COVID-19 Uninsured Program.

SARS-CoV-2 (COVID-19) Serology Testing Frequently Asked Questions

Please review the Clinical Labs of Hawaii frequently asked questions for answers regarding SARS-CoV-2 (COVID-19) serology testing.

SARS-CoV-2 (COVID-19) Serology Testing Available

Effective April 30, 2020, Clinical Labs of Hawaii began offering serology testing for SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).

United Healthcare Insurance March 1, 2020 Billing Update

Beginning March 1, 2020, United Healthcare Insurance will require prior authorization/notification for genetic and molecular testing performed in an outpatient setting.

Respiratory Panel by PCR

CLH offers the FilmArray Respiratory Panel from BioFire Diagnostics for the detection of 17 respiratory viruses and 3 bacteria from a single specimen. This panel does NOT test for the SARS-CoV-2 virus.

Biotin Interference Test Update

Biotin administration (especially in high doses) may impact common, immunoassay-based, laboratory tests.

Human Papillomavirus (HPV) New Methodology and Algorithm

CLH/PPPL will be performing Human Papillomavirus (HPV) testing locally on Oahu using the Aptima nucleic acid amplification assay.